Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
  • Wide range of unique reagents
  • Free Shipping
    Free shipping in EU on Orders > €500
  • Fast worldwide delivery
    Fast worldwide delivery

Nesvacumab Biosimilar – Anti-ANGPT2 mAb – Research Grade

Reference:
Size

100ug, 1MG

Isotype

IgG1-nd

Brand

ProteoGenix

Product type

Primary Antibodies

Clonality

Monoclonal Antibody

Expression system

Mammalian cells

Applications

Elisa, WB

Product nameNesvacumab Biosimilar - Anti-ANGPT2 mAb - Research Grade
SourceCAS 1296818-77-3
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsNesvacumab,REGN-910,ANGPT2,anti-ANGPT2
ReferencePX-TA1311
NoteFor research use only. Not suitable for human use.
IsotypeIgG1-nd
ClonalityMonoclonal Antibody

Description of Nesvacumab Biosimilar - Anti-ANGPT2 mAb - Research Grade

General information on Anti-ANGPT2[Homo sapiens] (Nesvacumab) Monoclonal Antibody

Nesvacumab is investigated for the treatment of Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME).

Nesvacumab Biosimilar - Anti-ANGPT2 mAb binds to Humand ANGPT2 in indirect ELISA Assay

Immobilized Human ANGPT2-Ang2 recombinant protein (cat. No. PX-P6245) at 0.5µg/mL (100µL/well) can bind Nesvacumab Biosimilar - Anti-ANGPT2 mAb (cat. No. PX-TA1311) in indirect ELISA with Goat Anti-human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 16.93M.

Publication

Sim, M., Ohnuki, H., Durell, S. et al. Angiopoietin-2 binds to FGFR2, inhibits FGF-FGFR2 signaling, and delays cutaneous wound healing by inhibiting wound angiogenesis. Angiogenesis 28, 43 (2025). https://doi.org/10.1007/s10456-025-09988-2

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Nesvacumab Biosimilar – Anti-ANGPT2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human ANGPT2-Ang2 recombinant protein
Antigen

Human ANGPT2-Ang2 recombinant protein

PX-P6245 420€
Nesvacumab ELISA Kit
ELISA

Nesvacumab ELISA Kit

KPTX117 1179€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

    Cart (0 Items)

    Your cart is currently empty.

    View Products